Evrofarma S.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
23,467.00
25,272.00
29,646.00
28,906.00
30,986.00
32,985
Cost of Goods Sold (COGS) incl. D&A
19,099.00
19,012.00
22,807.00
23,577.00
25,440.00
26,952
Gross Income
4,368.00
6,260.00
6,839.00
5,329.00
5,546.00
6,033
SG&A Expense
4,193.00
5,174.00
4,342.00
3,902.00
3,587.00
4,156
EBIT
175.00
1,086.00
2,497.00
1,582.00
1,959.00
1,877
Unusual Expense
-
220.00
370.00
304.00
210.00
36
Non Operating Income/Expense
424.00
255.00
5.00
64.00
267.00
10
Interest Expense
1,199.00
1,293.00
979.00
915.00
791.00
864
Pretax Income
599.00
268.00
1,153.00
907.00
1,111.00
1,261
Income Tax
201.00
548.00
626.00
495.00
575.00
282
Consolidated Net Income
398.00
280.00
527.00
412.00
536.00
979
Net Income
398.00
280.00
527.00
412.00
536.00
979
Net Income After Extraordinaries
398.00
280.00
527.00
412.00
536.00
979
Net Income Available to Common
398.00
280.00
527.00
412.00
536.00
979
EPS (Basic)
0.03
0.02
0.04
0.03
0.04
0.07
Basic Shares Outstanding
13,673.20
13,673.20
13,673.20
13,673.20
13,673.20
13,673.20
EPS (Diluted)
0.03
0.02
0.04
0.03
0.04
0.07
Diluted Shares Outstanding
13,673.20
13,673.20
13,673.20
13,673.20
13,673.20
13,673.20
EBITDA
2,575.00
2,785.00
4,003.00
3,031.00
3,244.00
3,245
Other Operating Expense
-
-
-
155.00
-
-
Non-Operating Interest Income
1.00
-
-
-
-
-
About Evrofarma
View Profile
